Aismay Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 20

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 12

Aismay General Information

Description

Developer of cancer therapeutics designed for immuno-oncology and bispecific antibody drugs. The company's pharmaceutical products aim to treat and reduce symptoms of various kinds of cancers, enabling healthcare professionals to prescribe more effective treatments to their patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 511, 5th Floor, Building B10
  • Number 11 Kaiyuan Avenue, Huangpu District
  • Guangzhou, Guangdong 510530
  • China
+86 020
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Room 511, 5th Floor, Building B10
  • Number 11 Kaiyuan Avenue, Huangpu District
  • Guangzhou, Guangdong 510530
  • China
+86 020

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aismay Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC 29-Jul-2026 Completed Generating Revenue
9. Later Stage VC 19-Jan-2024 Completed Generating Revenue
8. Secondary Transaction - Private 13-Jan-2022 Completed Generating Revenue
7. Later Stage VC 12-Jan-2022 Completed Generating Revenue
6. Later Stage VC 20-Aug-2021 Completed Clinical Trials - General
5. Secondary Transaction - Private 12-Mar-2020 Completed Clinical Trials - General
4. Early Stage VC (Series A1) 14-Jan-2020 Completed Clinical Trials - General
3. Early Stage VC 30-Jul-2019 Completed Clinical Trials - General
2. Early Stage VC (Series A) 03-Jan-2018 $725K Completed Clinical Trials - General
1. Seed Round 01-Feb-2017 $725K $725K Completed Startup
To view Aismay’s complete valuation and funding history, request access »

Aismay Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aismay Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Intellective Bio VC-Backed Company Minority
Wanlian Tianze Capital Investment Venture Capital Minority
Hangzhou Tailong Venture Capital Partnership Growth/Expansion Minority
TigerYeah Capital Venture Capital Minority
Delta Capital Venture Capital Minority
You’re viewing 5 of 12 investors. Get the full list »

Aismay FAQs

  • When was Aismay founded?

    Aismay was founded in 2016.

  • Where is Aismay headquartered?

    Aismay is headquartered in Guangzhou, China.

  • What is the size of Aismay?

    Aismay has 20 total employees.

  • What industry is Aismay in?

    Aismay’s primary industry is Drug Discovery.

  • Is Aismay a private or public company?

    Aismay is a Private company.

  • What is Aismay’s current revenue?

    The current revenue for Aismay is .

  • How much funding has Aismay raised over time?

    Aismay has raised $16.2M.

  • Who are Aismay’s investors?

    Intellective Bio, Wanlian Tianze Capital Investment, Hangzhou Tailong Venture Capital Partnership, TigerYeah Capital, and Delta Capital are 5 of 12 investors who have invested in Aismay.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process